GlycoMimetics, Inc.

Historical 13F Holders

Symbol
GLYC
CUSIP
38000Q102
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 38000Q102 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Weinstein Benjamin 13G/A 0.1% 11/4/2024
Event 10/30/2024
RA Capital Management, L.P. 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 39 30.8 M $6.46 M
2024 Q4 44 30.4 M $7.56 M
2024 Q3 38 17.8 M $3.00 M
2024 Q2 46 25.6 M $7.20 M
2024 Q1 86 37.1 M $111 M
2023 Q4 67 37.6 M $88.8 M
2023 Q3 52 34.7 M $52.1 M
2023 Q2 60 35.6 M $61.9 M
2023 Q1 67 37.0 M $46.6 M
2022 Q4 54 27.7 M $83.8 M
2022 Q3 36 25.9 M $14.3 M
2022 Q2 39 26.5 M $15.8 M
2022 Q1 47 27.4 M $31.7 M
2021 Q4 57 30.0 M $43.1 M
2021 Q3 54 29.7 M $64.9 M
2021 Q2 64 31.3 M $72.5 M
2021 Q1 83 36.7 M $110 M
2020 Q4 99 39.9 M $150 M
2020 Q3 88 42.5 M $130 M
2020 Q2 90 40.4 M $152 M
2020 Q1 80 39.7 M $90.6 M
2019 Q4 82 43.0 M $227 M
2019 Q3 81 42.6 M $183 M
2019 Q2 87 46.0 M $549 M
2019 Q1 85 45.5 M $567 M
2018 Q4 83 45.6 M $432 M
2018 Q3 95 46.6 M $671 M
2018 Q2 91 46.4 M $749 M
2018 Q1 91 43.8 M $709 M
2017 Q4 85 31.9 M $535 M
2017 Q3 62 29.8 M $416 M
2017 Q2 72 30.3 M $338 M
2017 Q1 46 19.1 M $104 M
2016 Q4 52 19.0 M $116 M
2016 Q3 48 18.4 M $132 M
2016 Q2 50 18.5 M $135 M
2016 Q1 31 14.1 M $83.8 M
2015 Q4 30 13.9 M $79.3 M
2015 Q3 31 13.8 M $77.4 M
2015 Q2 32 13.8 M $109 M
2015 Q1 29 13.7 M $114 M
2014 Q4 29 13.9 M $100 M
2014 Q3 27 13.4 M $93.0 M
2014 Q2 31 13.5 M $114 M
2014 Q1 37 14.1 M $230 M